 |
|
|
| |
Real-World Cost-per-SVR with Simeprevir/Sofosbuvir ±
Ribavirin.... 88% SVR/76% SVR in PI-Experienced
|
| |
| |
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Kian Bichoupan1, Neeta Tandon2, Rachana Yalamanchili1, Neal M. Patel1 , Sweta Chekuri1, Alyson Harty1, Thomas Schiano1, Ponni V. Perumalswami1, Douglas Dieterich1, Andrea D. Branch1
1. Mount Sinai School of Medicine, New York, NY, United States.
2. Health Economics & Outcomes Research, Janssen Scientific Affairs, Titusville, NJ, United States.
webcast:
http://www.croiwebcasts.org/console/player/25806?mediaType=slideVideo&
76% of patients with previous PI experience achieved SVR
|
| |
|
|
|
|
|
